Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-24-037001
Filing Date
2024-12-09
Accepted
2024-12-09 17:11:06
Documents
2
Period of Report
2024-12-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 - IT 12.09.24 rdgdoc.html 3  
1 FORM 3 - IT 12.09.24 rdgdoc.xml 3 3671
2 ietpoa.htm EX-24 4423
  Complete submission text file 0001437749-24-037001.txt   9550
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Issuer) CIK: 0001710340 (see all company filings)

EIN.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 52 OTIS RD BARRINGTON IL 60010
Business Address
Erdogan-Trinkaus Ipek (Reporting) CIK: 0002047026 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38738 | Film No.: 241535951